Difference Between a Retatrutide COA and a Retatrutide SDS

The difference between a retatrutide COA and a retatrutide SDS comes down to what each document is measuring: a Certificate of Analysis (COA) reports what is actually in a specific vial lot, while a Safety Data Sheet (SDS) describes how to handle the compound as a chemical substance, regardless of which lot it came from. Both documents can appear on the same supplier listing, and both matter for different reasons, but they answer different questions and neither can substitute for the other.

What a COA Actually Reports

A Certificate of Analysis is a lot-specific lab report. When a manufacturer or a third-party lab tests a batch of retatrutide, the COA documents the results of that testing against the vial or batch it came from. A well-formed retatrutide COA typically includes:

• A lot or batch number that ties the document to the physical vial
• An identity test result, usually mass spectrometry, confirming the peptide is what it claims to be
• A purity percentage, usually from HPLC (high-performance liquid chromatography)
• Sometimes a peptide content or net weight figure, which is distinct from purity
• A test date and the name of the lab that performed the analysis

Because a COA is lot-specific, it should change every time the underlying batch changes. A listing that displays the exact same COA image across multiple restocks, with no updated lot number or date, is not describing the vial currently being sold. This is one of the more common shortcuts to watch for when reading a retatrutide COA against a listing.

What an SDS Actually Reports

A Safety Data Sheet is a standardized document format used across the chemical industry, not something unique to peptide suppliers. An SDS for retatrutide covers the substance generally rather than any specific lot. Typical SDS sections include:

• Hazard identification and handling precautions
• Storage conditions and stability information
• First-aid and spill-response guidance
• Physical and chemical properties
• Regulatory and transport classification

An SDS does not tell you the purity of the vial in front of you, and it does not confirm the vial contains what the label says. It is a reference document about the compound as a category, formatted the same way whether the source vial was tested yesterday or never tested at all.

Side-by-Side Comparison

	COA	SDS
Scope	Specific to one lot or batch	General to the compound
Confirms identity/purity	Yes	No
Changes between restocks	Should, if lot changes	Rarely, unless formulation changes
Primary audience	Buyer verifying vial contents	Handler managing storage/safety
Typical source	Testing lab	Manufacturer safety documentation
Answers “what is in this vial”	Yes	No

Why Listings Sometimes Only Show One

Some supplier listings publish an SDS but not a COA, or the reverse. An SDS is easier to produce because it does not require testing a specific batch; it can be written once and reused indefinitely. A COA requires paying for lab work on each new lot, so a listing that skips it is often cutting a cost rather than an oversight. When comparing retatrutide listings, a COA that is lot-matched and dated close to the sale is a stronger signal of current-batch testing than an SDS alone, since the SDS was never designed to answer that question.

That does not make the SDS irrelevant. It is the correct document to reference for handling and storage questions, and its absence from a listing can be its own signal about how much documentation a supplier maintains overall. Buyers comparing documentation practices across suppliers, including the breadth of a catalogue like the one at HEEZ Research, will typically find both COA and SDS documents referenced separately rather than one standing in for the other.

Reading a COA Against the Listing

Once a COA is available, matching it to the listing takes a few checks:

1. Confirm the lot number on the COA matches the lot number printed on the vial or listed alongside it.
2. Check the test date. A COA dated years before the current sale describes an earlier batch, not necessarily the one being shipped now.
3. Look for both an identity test and a purity percentage. A document with only one of the two is incomplete for verifying contents.
4. Note which lab performed the testing. In-house testing and independent third-party testing are not interchangeable claims, and a listing should specify which one applies.

None of these checks require lab equipment. They are document-reading steps, and they apply equally whether the listing calls the document a COA, a certificate of purity, or a lab report.

Where This Distinction Matters Most

The COA vs SDS distinction matters most when a listing uses the two documents interchangeably, presenting an SDS as if it answers a purity question, or omitting a COA while pointing to an SDS as general reassurance. Since an SDS says nothing about a specific batch’s identity or purity, it cannot fill that gap. A listing that provides only an SDS has told a reader how to store and handle the compound, not what is actually inside the vial being sold.

Summary

A retatrutide COA is a lot-specific lab report confirming identity and purity for a particular batch, while an SDS is a general handling and safety reference that applies to the compound as a substance. Both can appear on a legitimate listing, but only the COA speaks to what is actually in a given vial, and only when its lot number and date align with the batch being sold.